Research Article
Volume 1 Issue 1 - 2015
Intravenous Low Dose Ketamine Injection versus Dexmedetomidine Infusion for Prevention of Intraoperative Shivering During Spinal Anesthesia: A Prospective Randomized Controlled Study
Mostafa Mansour Houssein* and Ibrahim Mohamed Ibrahim
Department of anesthesia and intensive care, Ain Shams University, Egypt
*Corresponding Author: Mostafa Mansour Houssein, Department of anesthesia and intensive care, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Received: February 20, 2015; Published: March 27, 2015
Citation: Mostafa Mansour Houssein and Ibrahim Mohamed Ibrahim. “Intravenous Low Dose Ketamine Injection versus Dexmedetomidine Infusion for Prevention of Intraoperative Shivering During Spinal Anesthesia: A Prospective Randomized Controlled Study”. EC Anaesthesia 1.1 (2015): 22-30.
Background: Shivering is considered one of the most common adverse effects occurring during spinal anesthesia. Besides causing patient discomfort, shivering also interferes with patient monitoring and increases tissue oxygen demand. The present study was conducted to compare the effectiveness of iv low dose Ketamine (0.25 mg/kg) and dexmedetomidine iv infusion in prevention of shivering during spinal anesthesia.
Materials and Methods: Sixty patients of both sexes were included in this prospective randomized controlled study. Patients were divided randomly into two group’s thirty patients each. Group K (30 patients) received low dose Ketamine (0.25 mg/kg) and group D (30 patients) received Dexmedetomidine infusion. The primary outcome measures of this study were intraoperative shivering. Secondary outcome measures were hemodynamic changes, sedation scores and postoperative side effects.
Results: Patients in group D had a lower incidence of post spinal anesthesia shivering compared to patients in group K. 13.33% of group K patients reached grade 3 shivering in comparison to only 3.33% of patients in group D 10 min. after onset of spinal anesthesia (p = 0.031). Deeper sedation was observed in group D patients as 36.67% of group D patients reached grade 4 sedation compared to 23.33% of patients in group K after 10 minutes (p = 0.048)
Conclusion: Dexmedetomidine infusion is more effective as an anti-shivering and sedating agent than low dose Ketamine injection in patients receiving spinal anesthesia.
Keywords: Spinal anesthesia; Ketamine; Dexmedetomedine; Shivering
Shivering is considered one of the common complications occurring during spinal anesthesia and its incidence was reported to reach up to 56.7% [1,2]. Shivering leads to patient inconvenience and also interfere with monitoring of electrocardiogram (ECG), blood pressure (BP), and oxygen saturation. It increases oxygen consumption, carbon dioxide production and may lead to lactic acidosis. It also increases intracranial and intraocular pressures [3,4].
The normal human core temperature usually ranges from 36.5ºC to 37.5ºC [5]. Thermoregulation (which is a part of homeostatic mechanism) is done at the level of the anterior hypothalamus. The anterior hypothalamus compares the peripheral inputs with a threshold value, or the set-point. if the temperature was lower than this set point, this will activate certain reflexes to warm the body, while If the temperature was higher than this set point, this will trigger a cooling responses [6].
Both cooling and worming responses are decreased during regional anesthesia, suggesting affection in central, rather than peripheral control [7]. Impairment of centrally mediated thermoregulation by the local anesthetics is usually caused by alteration in the afferent thermal inputs from legs. All thermal inputs from the blocked regions are interrupted by regional anesthesia, which is primarily cold information. This decrease in cold information is then interpreted by the brain as relative leg warming [8].
Various methods are available to control shivering during anesthesia. These methods are either pharmacological or non-pharmacological. Pharmacological methods use drugs which have anti-shivering properties like clonidine, pethidine, nefopam, tramadol, ketanserine, doxapram, etc. This method is cost effective, simple, and easy to implement. The non-pharmacological methods using equipment to maintain normal temperature of the body are effective but expensive and lack practicality.
Recently, Ketamine and Dexmedetomidine have been tried to prevent shivering during anesthesia with good results. Ketamine (a competitive NMDA receptor antagonist) has a role in thermoregulation at various levels. NMDA receptor modulates serotonergic and nor-adrenergic neurons in locus ceruleus. It is used as anti-shivering agent in a dose of 0.25 - 0.75 mg/kg IV. But even in these doses, it causes side effects (i.e. drowsiness, delirium, hallucination) [9,10].
Dexmedetomidine is a highly selective α 2 - adrenergic receptor agonist with potent effects on the central nervous system [11,12]. Although Dexmedetomidine is among several pharmacological agents used for the treatment of shivering, its effects as anti-shivering during central neuroaxial blockade have not been evaluated to date.
Aim of the study: The aim is to compare between intravenous low dose of Ketamine and intravenous infusion of dexmedetomidine for prevention of intraoperative shivering during spinal anesthesia.
Materials and Methods
This prospective randomized controlled study was carried out at Ain - Shams University Hospital after obtaining the approval of the local ethical committee. The study design was assigned as parallel with active control group. The study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN 12614001246673). Date of registration was 27/11/2014, registered by Mostafa Mansour Houssein.
Sixty patients of both sexes between 20 to 50 years old undergoing elective lower abdominal surgery and elective orthopedic lower limb surgery were included in the study. Patients selected were American Society of Anesthesiologists (ASA) I and II physical status. After approval of local ethics committee, all subjects gave written consents to participate. Patients with thyroid disease, parkinson΄s disease, dysautonomia, Raynaud΄s syndrome, cardiopulmonary disease, a need for blood transfusion during surgery, a history of allergy to the agents to be used, an initial core temperature > 37.5ºC or < 36.5ºC, a known history of alcohol use, use of sedative - hypnotic agents, use of vasodilators, or having contraindications to spinal anesthesia were excluded from the study. All operation theatres in which the operations were performed maintained at constant humidity 70% and an ambient temperature of around 23ºC. Irrigation and i.v. fluids were administered at room temperature and given without in line warming. No other warming device was used. A core temperature below 36ºC was considered hypothermia. Before performing spinal anesthesia, each patient received 10 ml/kg of lactated Ringer’s solution. Before beginning of spinal anesthesia, standard monitoring of heart rate, non-invasive blood pressure (NIBP), oxygen saturation (SpO2) and body temperature (axillary) were recorded and then every 10 minutes. Subarachnoid anesthesia was instituted at either L3/4 or L4/5 inter space with 3 ml of 0.5% hyperbaric Bupivacaine (Marcaine®, spinal heavy 0.5%, AstraZeneca) using 25 gauge Quincke΄s needle, and blockade up to T9 - T10 dermatome was achieved. Motor block was assessed using a modified Bromage scale (0 = no motor block, 1 = can flex knee, move foot but cannot raise leg, 2 = can move foot only, 3 = cannot move foot or knee) [13]. Sensory block was assessed by the pinprick test.
After spinal anesthesia, group K received a prophylactic low dose of Ketamine (0.25 mg/kg), while group D received a prophylaxis of Dexmedetomidine (Precedex®). Dexmedetomidine ampoule (200 µg/ml) was diluted to a volume of 50 ml (4 µg/ml). Patients received a dosed of 1 µg/kg dexmedetomidine over 10 min. by a syringe pump (perfuser compact, Braun, Germany) followed by continuous infusion of 0.4 µg/kg/h during the surgery which was stopped at the completion of surgery. Supplemental oxygen (2 L/min.) was delivered via a nasal cannula during the operation.
Grading of shivering was done which is as following: [14]
Grade 0: No shivering
Grade 1: Peripheral vasoconstriction or Piloerection or peripheral cyanosis without visible muscle activity.
Grade 2: Visible muscle activity confined to one muscle group.
Grade 3: Visible muscle activity in more than one muscle group.
Grade 4: Gross muscle activity involving the whole body.
If shivering grade was 3 or greater at 15 minutes after spinal anesthesia, the prophylaxis was considered ineffective, and 25mg Pethidine was administered by i.v. route.
Side effects like nausea, vomiting, bradycardia (< 60/min.), hypotension (> 20% decline below baseline), dizziness, and sedation were recorded.
The degree of sedation was assessed using a 5 points scale: [15]
1 = fully awake and oriented patient.
2 = Drowsy.
3 = eyes closed, arousable on command.
4 = eyes closed, arousable to physical stimuli.
5 = eyes closed, unarousable to physical stimuli.
If the patient’s heart rate drops below 60 beat/min. 0.5 mg atropine was administered by i.v. route. If mean arterial pressure (MAP) drop more than 20% from baseline, 10 mg ephedrine via i.v. bolus is given and further i.v. infusion of lactated Ringer’s solution is required. If the patients developed nausea and vomiting, 10 mg metoclopramide was administered through i.v. route. Heart rate, mean arterial pressure (MAP), temperature and oxygen saturation (SpO2) were recorded as a baseline before the start of spinal anesthesia then recorded every 10 minutes during intra-operative period till the end of operation.
The primary outcome measures were intraoperative shivering score. Secondary outcome measures were hemodynamic parameters (heart rate, mean arterial pressure, oxygen saturation and temperature) measured at baseline then every 10 min., sedation scores and postoperative side effects (e.g. nausea, vomiting, and dizziness).
Statistical Analysis
Sample size was calculated using PASS 11. Based on a pilot study, it was calculated that a sample size of 24 patients per group will achieve 80% power to detect a 10% decrease in the occurrence in shivering in the dexmedetomidine group compared to ketamine group. The significance level of the test was targeted at 0.0500. Thirty patients per group were included to replace any dropouts.
Methods of Randomization
  1. Randomization of patients was done using a computerized program (SPSS).
  2. Sealed envelopes were numbered according to the randomization tables.
  3. Packing, sealing and numbering of the envelop was performed by a neutral medical personnel (Under the supervision of doctors from the Department of Anesthesiology).
  4. The number of cases included in this study was simple randomly allocated into two groups (30 in each group).
Data were analyzed using Statistical Program for Social Science (SPSS) version 18.0. Quantitative data were expressed as mean ± standard deviation (SD). Qualitative data were expressed as frequency and percentage.
The following tests were done
  1. Paired sample t-test of significance was used when comparing between related samples.
  2. Chi-square (X2) test of significance was used in order to compare proportions between two qualitative parameters.
  3. Probability (P-value): P-value ≤ 0.05 was considered significant. P-value 0.01 was considered as highly significant.
Comparison of the demographic data (age, sex, weight, height, ASA physical status, duration of surgery, type of surgery) showed no statistically significant difference between the two groups. (P > 0.05) (Table 1)
  Group (K) Group (D) t-test
  Mean ± SD Mean ± SD t/*x2 p-value
Age (years) 33.86 12.04 35.22 9.36 0.339 0.692
Body Weight (Kg) 71.92 17.22 74.22 12.17 0.488 0.628
Height (cm) 169.31 11.96 174.53 14.93 1.220 0.229
Duration of Surgery (min) 48.83 13.22 51.12 9.63 0.626 0.535
  No. % No. % - -
Gender Male 17 56.67 14 46.67 *0.267 0.066
  Female 13 43.33 16 53.33 - -
ASA I 8 26.67 11 36.67 *0.308 0.578
  II 22 73.33 19 63.33 - -
Type of surgery Lower Abdominal surgery 12 40.00 11 36.67 *0.163 0.892
Lower limp Orthopedic surgery 18 60.00 19 63.33 - -
Table 1: Characteristics of patients in the two groups. Data are expressed as frequency and percentage or mean (SD).
*x2 - Chi-square test; t - independent - sample t - test; p - value > 0.05 NS.
This table shows no statistically significant difference between the two groups as regards patient’s characteristics.
These tables (Tables 2,3,4) show that there are statistically significance differences between the two groups as regard HR, MAP and temperature. Heart rate and mean arterial pressure (MAP) were lower in group D in comparison with group K especially at 50 minutes with a HR mean (SD) of 67.82 ± 6.38 bpm and MAP mean (SD) of 69.30 ± 15.86 mmHg and also at 60 minutes with a HR mean (SD) of 67.12 ± 9.83 bpm and MAP mean (SD) of 65.30 ± 14.86 mmHg.
Body temperature was lower in group K than group D beginning from first 10 minutes with mean ± SD of 36.60 ± 0.20 at 10 minutes. There was no statistically significant difference between the two groups regarding oxygen saturation (SpO2). (P > 0.05)
Hemodynamic Base line After 10 min. After 20 min. After 30 min. After 40 min. After 50 min. After 60 min.
  Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
HR Group (K) 70.53 7.11 77.12* 9.26 79.42* 10.56 81.72† 9.46 84.02† 8.36 84.32† 7.26 84.44† 6.16
Group (D) 70.23 9.42 73.11 13.60 72.68 21.83 71.72 12.62 69.42 5.55 67.82 6.38 67.12 9.83
p-value 0.936 0.456 0.391 0.060 < 0.001 < 0.001 < 0.001
Table 2: Follow up of HR in the two groups.
*p - Value < 0.05 vs. Group D significant.
†p - Value < 0.01 vs. Group D highly significant.
Hemodynamic Base line After 10 min. After 20 min. After 30 min. After 40 min. After 50 min. After 60 min.
  Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
MAP Group (K) 90.43 8.32 94.83* 22.92 97.33† 19.92 101.73† 17.52 103.33† 14.82 104.73† 17.82 104.33† 14.82
Group (D) 90.31 7.91 84.30 13.86 81.30 15.86 77.30 17.86 73.30 16.86 69.30 15.86 65.30 14.86
p-value 0.971 0.229 0.062 0.006 <0.001 <0.001 <0.001
Table 3: Follow up of MAP in the two groups.
*p - value < 0.05 vs. Group D significant.
†p - value < 0.01 vs. Group D highly significant.
Hemodynamic Base Line After 10 min. After 20 min. After 30 min. After 40 min. After 50 min. After 60 min.
  Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
SPO2 Group (K) 96.10 2.89 96.21 2.20 97.31 3.20 98.41 1.20 99.21 2.20 98.41 3.20 97.31 3.13
Group (D) 96.39 2.76 94.81 1.20 95.71 2.20 96.91 0.20 97.73 1.20 96.91 2.20 95.78 2.80
p-value 0.832 0.092 0.209 0.003 0.078 0.237 0.264
Table 4: Follow up of SPO2 in the two groups.
Table 6 and figure 1 show the relation between the two groups as regards shivering. Shivering is considered significant when the patient reaches at least to grade 3 and after 10 minutes of spinal anesthesia. After 10 minutes, 4 patients of Ketamine group reached grade 3 shivering with a percentage of 13.33 %, while only 1 patient of Dexmedetomidine group reached grade 3 with a percentage of 3.33%. After 20 minutes, 2 patients (6.67%) in Ketamine group reached grade 3 shivering while only 1 patient (3.33%) of Dexmedetomidine group reached group 3. Grade 4 shivering was not noted in any patient in either group.
Table 6 shows that there was a statistically significant difference between the two groups as regard shivering score after 10min and after 20 min. Shivering was less in group D especially after 10 and 20 minutes.
Patients in group D were more sedated than patients in group K. After 10 minutes, 11 patients (36.67%) in group D reached grade 4 sedation while only 7 patients (23.33%) in group K reached grade 4 sedation. After 20 minutes, 12 patients (40 %) in group D reached grade 4 sedation while only 7 patients (23.33%) in group K reached grade 4 sedation. No patients in either group reached grade 5 sedation (Table 5).
Hemodynamic Base line After 10 min. After 20 min. After 30 min. After 40 min. After 50 min. After 60 min.
  Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Temperature Group (K) 36.70 0.11 36.60* 0.20 36.70* 0.05 36.70* 0.08 36.70* 0.09 36.80* 0.06 36.80* 0.15
Group (D) 36.71 0.14 36.75 0.06 36.81 0.05 36.82 0.03 36.91 0.05 37.00 0.06 37.10 0.04
p-value 0.861 0.056 0.041 0.037 < 0.001 < 0.001 < 0.001
Table 5: Follow up of temperature in the two groups: *p - value < 0.05 vs. Group D significant.
†p - value < 0.01 vs. Group D highly significant.
Data are expressed as mean (SD) for parametric data.
t - Independent - sample t – test.
Table 7 shows that there was a statistically significant difference between the two groups as regards sedation (score) after 10 min and after 20 min. Patients were more sedated in group D especially after 10 and 20 minutes.
4 patients (13.33%) in group D had postoperative dizziness in comparison with 3 patients (10%) in group K. 3 patients (10%) in group D experienced intra - operative nausea and vomiting in comparison with 2 patients (6.67%) in group K (Table 6).
Category time Shivering Score Chi-Square Test
Group (K) Group (D)  
Score (0) Score (1) Score (2) Score (3) Score (0) Score (1) Score (2) Score (3) x2 p-value
After 10 min. No. 14 7 3 4 24 3 2 1 8.062 0.031
% 46.67 23.33 10.00 13.33 80.00 10.00 6.67 3.33    
After 20 min. No. 15 7 6 2 23 5 1 1 7.111 0.046
% 50.00 23.33 20.00 6.67 76.67 16.67 3.33 3.33    
After 30 min. No. 19 4 4 3 21 6 2 1 1.382 0.783
% 63.3 13.3 13.3 10.0 70.0 20.0 6.7 3.3    
After 40 min. No. 20 5 3 2 23 3 2 2 2.326 0.433
% 66.7 16.7 10.0 6.7 76.7 10.0 6.7 6.7    
After 50 min. No. 21 6 2 1 22 5 3 0 1.893 0.601
% 70.0 20.0 6.7 3.3 73.3 16.7 10.0 0.0    
After 60 min. No. 19 5 3 3 20 7 2 1 2.500 0.367
% 63.3 16.7 10.0 10.0 66.7 23.3 6.7 3.3    
Table 6: Shivering score in the two groups.
Data are expressed as frequency and percentage data.
x2- Chi-square test.
Table 8 shows that, there was no statistically significant difference between the two groups as regard nausea & vomiting; and dizziness.
The present study showed that a loading dose of dexmedetomidine of 1 µg/kg followed by continuous administration at an infusion rate of 0.4 µg/kg/hr produced potent anti-shivering effect with adequate level of sedation. However, there was a tendency for the incidence of hypotension and bradycardia compared with low dose Ketamine.
Dexmedetomidine which is an α-2 adrenoceptor agonist (it has eight times higher affinity for the α-2 adrenoceptor than clonidine), produces its sedative and anxiolytic action through binding to α-2 adrenoceptors in the locus ceruleus, resulting in decrease in the release of norepinephrine with inhibition of sympathetic activity, thus decreasing heart rate and blood pressure [16]. Hypotension and bradycardia in dexmedetomidine group is augmented by the addition of the hypotensive and bradycardic effects of spinal anesthesia after reaching maximum sensory block levels. Bradycardia with dexmedetomidine infusion was increased only in cases with a loading dose.
The motor shivering center exists near to the posterior hypothalamus which receives impulses from cold receptors. Upon activation of this shivering center by the cold impulses, it sends bilateral impulses to anterior horn cells in the spinal cord resulting in increase in the tone of the skeletal muscles all over the body. Shivering is observed when muscle tone is increased above certain level [17].
The etiology of post - spinal shivering is inadequately understood. Meperidine (Pethidine), which binds to both κ-opioid and mu receptors, is usually recommended for the treatment of postoperative shivering and the anti - shivering action of meperidine has previously been attributed to its action on κ-opioid receptors [18].
Shivering is a thermoregulatory response to cold, and can complicate both general and neuroaxial anesthesia. General anesthesia causes impairment in the thermoregulatory mechanism characterized by a decrease in cold response threshold from 0.4 ͦC to 4 ͦC and an increase in worm response threshold. Some of the causative factors of this type of shivering may be common to both general and neuroaxial anesthesia, but some are particular to neuroaxial anesthesia [19]. Shivering may have beneficial thermoregulatory effects, but on the other hand it places the body under increased physiological stress. This physiological stress includes increase in oxygen consumption and carbon dioxide production, and increased cardiac work. Therefore, the prevention of shivering is more important than its treatment [19].
We found that not all patients who develop shivering are hypothermic and post spinal shivering is not necessarily associated with core hypothermia. Shivering can occur in patients who are normothermic.
Our results are consistent with the study done by Elvan., et al. [20] who reported that dexmedetomidine infusion during surgery was effective in the prevention of post - anesthetic shivering in patients undergoing elective abdominal hysterectomy.
Another study done by Bicer and colleagues in 2006 [21] founded that the incidence of shivering was 15% with dexmedetomidine and 55% with placebo following general anesthesia. Also, Coskuner., et al. [22] did not observe shivering with the same dose used in our study.
Bicer., et al. [21] reported that intraoperative intravenous dexmedetomidine of 1.0 µg/kg reduces post anesthetic shivering with effects comparable to those of Meperidine0.5mg/kg.
Many studies were done to detect the effect of Ketamine on the incidence and severity of anesthesia related shivering. Dal., et al. [23] showed that ketamine 0.5 mg/kg was effective in prevention of post anesthetic shivering in patients receiving general anesthesia. Sagir., et al. [24] showed that 0.5 mg/kg of ketamine was also effective in prevention of shivering during spinal anesthesia. In our study, 0.25 mg/kg of ketamine was also as effective as 0.5 mg/kg of ketamine. The shivering was seen in 13.33% of group K patients who reached grade 3 shivering in comparison with only 3.33% of patients in group D 10 min. after onset of spinal anesthesia (p = 0.031).
Nausea and vomiting are also one of the adverse effects of dexmedetomidine and occurring more frequent than in patients receiving ketamine. However, there are some studies showing no difference of dexmedetomidine compared with placebo for nausea [20].
Dexmedetomidine infusion exerts a beneficial dual effect as an anti-shivering and sedating agent during spinal anesthesia without any major adverse reactions. Therefore, we concluded that dexmedetomidine infusion is a good choice and better than low dose ketamine during spinal anesthesia when shivering is considered a problem.
  1. Chan AM., et al. “Control of shivering under regional anesthesia in obstetric patients with tramadol”. Canadian Journal of Anesthesia 46.3 (1999): 253-258.
  2. Jeon YT., et al. “Intrathecal clonidine does not reduce post-spinal shivering”. Acta Anaesthesiologica Scandinavica 49.10 (2005):1509-1513.
  3. Macintyre PE., et al. “Effect of meperidine on oxygen consumption, carbon dioxide production, and respiratory gas exchange in post anesthesia shivering”. Anesthesia & Analgesia 66.8 (1987): 751-755.
  4. Tsai YC, and Chu KS. “A comparison of tramadol, amitriptyline, and Meperidine for postepiduralanesthetic shivering inparturients”. Anesthesia & Analgesia 93.5 (2001): 1288-1292.
  5. Sellden E, and Lindahl S. “Aminoacid-induced thermogenesis reduces hypothermia during anaesthesia and shortens hospital stay”. Anesthesia & Analgesia 89 (1999): 1551-1556.
  6. Berti M., et al. “Hypothermia prevention and treatment”. Anaesthesia 53.Suppl.2 (1998):46-47.
  7. Joris J., et al. “Epidural anesthesia impairs both central and peripheral thermoregulatory control during generalanesthesia”. Anesthesiology 80.2 (1994): 268-277.
  8. Frank SM., et al. “Predictors of hypothermia during spinal anesthesia”. Anesthesiology 92.5 (2000): 1330-1334. 
  9. Dal D., et al. “Efficacy of prophylactic ketamine in preventing postoperative shivering”. British Journal of Anaesthesia 95 (2005): 189-192.
  10. Sagir O., et al. “Control of shivering during regional anaesthesia: prophylactic ketamine and granisetron”. Acta Anaesthesiologica Scandinavica 51.1 (2007): 44-49. 
  11. Doze VA., et al. “Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors”. Anesthesiology 71.1 (1989): 75-79. 
  12. Elvan EG., et al. “Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy”. European Journal of Anaesthesiology 25.5 (2008)357-364. 
  13. Bromage PR. “A comparison of the hydrochloride and carbon dioxide salt of lidocaine and prilocaine in epidural analgesia”. Acta Anaesthesiologica Scandinavica 16 (1965): 55-69.
  14. Tsai YC, and Chu KS. “A comparison of tramadol, amitriptyline, andmeperidine for postepidural anesthetic shivering inparturients”. Anesthesia & Analgesia 93.5 (2001): 1288-1292.
  15. Wilson E., et al. “Sedation during spinal anaesthesia: comparison of propofol and midazolam”. British Journal of Anaesthesia 64.1 (1990): 48-52.
  16. Jorm CM, and Stamford JA. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. British Journal of Anaesthesia 71.3 (1993): 447-449. 
  17. Guyton AC. “Body temperature, temperature regulation and fever”. In: Guyton AC, Hall JE. eds. Text book of medical physiology, 9th. Edition pheladelphia: W.B. Saunders (1996) 911-922.
  18. Takada K., et al. “Meperidine exerts agonist activity at the α2B-adrenoceptor subtype”. Anesthesiology 96.6 (2002): 1420-1426. 
  19. . Horn EP., et al. “Nonthermoregulatory shivering in patients recovering from isoflurane or desflurane anesthesia”. Anesthesiology 89.4 (1989): 878-886.
  20. Elvan EG., et al. “Dexmedetomidine and postoperative shivering in patients undergoing elective abdominal hysterectomy”. European Journal of Anaesthesiology 25.5 (2008): 357-364. 
  21. Bicer C., et al. “Dexmedetomidine and meperidine prevent postanaesthetic shivering”. European Journal of Anaesthesiology 23.2 (2006): 149-153. 
  22. Coskuner I., et al. “Effects of dexmedetomidine on the duration of anaesthesia and wakefulness in bupivacaine epidural block”. European Journal of Anaesthesiology 24.6 (2007): 535-540.
  23. Dal D., et al. “Efficacy of prophylactic ketamine in preventing postoperative shivering”. British Journal of Anaesthesia 95 (2005): 189-192.
  24. Sagir O., et al. “Control of shivering during regional anaesthesia: prophylactic ketamine and granisetron”. Acta Anaesthesiologica Scandinavica 51.1 (2007): 44-49. 
Copyright: © 2015 Mostafa Mansour Houssein., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before September 28, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to